Inhibition of angiotensinogen in the treatment of hypertension-Reference-Cited by-同舟云学术

Inhibition of angiotensinogen in the treatment of hypertension

Published:2023-10-27 Issue:47 Volume:44 Page:4909-4910
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Braunwald Eugene¹²^ORCID

Affiliation:

1. TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital , Hale Building, Suite 7022, 60 Fenwood Road, Boston, MA 02115 , USA

2. Department of Medicine, Harvard Medical School , Boston, MA 02115 , USA

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/eurheartj/article-pdf/44/47/4909/54423863/ehad704.pdf

Reference14 articles.

1. Hypertension pharmacological treatment in adults: a World Health Organization guideline executive summary;Al-Makki;Hypertension,2022

2. Heart disease and stroke statistics-2022 update: a report from the American Heart Association;Tsao;Circulation,2022

3. Adherence in hypertension;Burnier;Circ Res,2019

4. ‘Drugs don’t work in patients who don't take them’ (C. Everett Koop, MD, US Surgeon General, 1985);Lindenfeld;Eur J Heart Fail,2017

5. Angiotensinogen: more than its downstream products: evidence from population studies and novel therapeutics;Kahlon;JACC Heart Fail,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zilebesiran: The First siRNA Drug Therapy for Hypertension;International Journal of Innovative Science and Research Technology (IJISRT);2024-07-11

2. Non-coding RNA therapeutics in the treatment of heart failure;European Heart Journal - Cardiovascular Pharmacotherapy;2024-04-19

3. Артериалдык гипертонияны дарылоо. Бир таблеткада амлодипин/валсартан менен айкалыштырылган дарылоого көңүл буруңуз;Scientific and practical journal Healthcare of Kyrgyzstan;2024-02-15